Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul Edward Kelly currently holds 502,295 shares of RELMADA THERAPEUTICS, INC. (RLMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Edward Kelly has been a net seller of RLMD stock. They have purchased $678.5K and sold $7.5M worth of shares.
Paul Edward Kelly's most recent insider trade was on Nov 5, 2025, when they purchased 90,000 shares at $2.20 per share.
Paul Edward Kelly serves as Executive at RELMADA THERAPEUTICS, INC. (RLMD). They have executed 51 insider transactions totaling $8.2M over their tenure at the company.
Paul Edward Kelly holds the position of Executive at RELMADA THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Paul Edward Kelly has shown a selling trading pattern, with $678.5K in total purchases and $7.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul Edward Kelly was on Jan 22, 2021, when they sold $6.4M worth of RLMD shares. This transaction involved 1,800 shares at $3543.00 per share.
Paul Edward Kelly currently owns 502,295 shares of RELMADA THERAPEUTICS, INC. (RLMD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul Edward Kelly's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul Edward Kelly has 51 Form 4 filings on record as an insider at RELMADA THERAPEUTICS, INC..
Set alerts for Paul Edward Kelly and 40,000+ other insiders.